Jones v. Pfizer

Case # 10-cv-03864
Case Name Jones v. Pfizer
Jurisdiction US District Court for S.D. NY

Plaintiffs allege that Defendants routinely marketed pharmaceuticals to physicians for uses that had not been approved by the Food and Drug Administration.  The also allege Defendants made illegal kickback payments to doctors to increase sales.  When these activities were revealed to the public, Defendants' stock price dropped and shareholders were financially harmed.

Final Approval Date 07/30/2015
  1. Final Approval granted.
  2. The Court granted reduced attorneys' fees, noting that suggestions of Objector Browne had been included in the Order (see Order Granting Attorneys' Fees at 7).
  3. Citing an improvement in the settlement of $34 million, Objector Browne motioned for an award of fees of $19,737.50.
  4. Objector Browne's motion was denied, with the Court noting that "Objector waived fee by not requesting same at the hearing at which the settlement was approved." (document attached below)
Dismissal of Last Appeal N/A
Attachments Docket Report.pdf
First Amended Class Action Complaint.pdf
Preliminary Approval Order.pdf
Final Judgment.pdf
Order Granting Attorneys' Fees.pdf
Order Denying Browne Motion for Fees.pdf
Added to Index
Last Updated

Objection of Scott W. Browne

Objectors Scott W. Browne
Signers Vincent S. Verdiramo
Attorneys Vincent S. Verdiramo
John J. Pentz
Edward W. Cochran
  1. Attorneys' fees are excessive and improperly calculated.

NOTE:  Attorney Cochran's participation was revealed when Objector Browne motioned for attorneys' fees and Attorney Pentz submitted billing records in support of the motion.

Attachments Objection of Scott W. Browne.pdf
Pentz Appearance for Objector Browne.pdf
Plaintiffs' Response to Browne Objection.pdf
Browne Motion for Attorneys' Fees.pdf
Pentz Declaration in Support of Browne Motion for Fees.pdf
Order Denying Browne Motion for Fees.pdf
Added to Index
Last Updated